Torrent Pharma Fact Sheet, Torrent Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Fact Sheet    (TORR)

Here is the latest financial fact sheet of Torrent Pharma. For more details, see the Torrent Pharma quarterly results and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

TORRENT PHARMA Price History

Price Rs 1,671.5
Mkt Cap Rs m 282,910
Vol '000 3.9
P/E X 57.9
P/CF X 26.0
EPS (TTM) Rs 28.9
% ch % 1.8
No. of shares m 169.26
% ch week % 0.3
% ch 1-mth % -2.2
% ch 12-mth % 2.9
52 week H/L Rs 1,964.0/1,453.0
(As on Oct 17, 2019 01:03:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TORRENT PHARMA Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
TORRENT PHARMA EQUITY SHARE DATA
High Rs5781,2321,7201,7681,550 
Low Rs3345231,1341,1861,144 
Sales per share (Unadj.) Rs247.3275.0394.5346.1354.7 
Earnings per share (Unadj.) Rs39.244.4102.455.240.1 
Diluted earnings per shareRs39.244.4102.455.240.1 
Cash flow per share (Unadj.) Rs44.455.6116.573.364.2 
Dividends per share (Unadj.) Rs10.0011.2540.0014.0014.00 
Adj. dividends per shareRs10.0011.2539.9914.0014.00 
Dividend yield (eoy) %2.21.32.80.91.0 
Book value per share (Unadj.) Rs112.4156.2206.5257.1273.1 
Adj. book value per shareRs112.4156.1206.4257.0273.1 
Shares outstanding (eoy) m169.22169.22169.22169.22169.22 
Bonus/Rights/Conversions  B1:1---- 
Price / Sales ratio x1.83.23.64.33.8 
Avg P/E ratio x11.619.813.926.833.6 
P/CF ratio (eoy) x10.315.812.320.121.0 
Price / Book Value ratio x4.15.66.95.74.9 
Dividend payout %25.525.439.125.434.9 
Avg Mkt Cap Rs m77,190148,465241,435249,887227,897 
No. of employees `0009.511.010.911.814.7 
Total wages/salary Rs m7,4118,4188,4249,93411,353 
Avg. sales/employee Rs Th4,386.54,212.46,129.64,971.54,083.0 
Avg. wages/employee Rs Th776.8762.0773.4843.2772.3 
Avg. net profit/employee Rs Th695.9679.81,591.3792.4461.3 
TORRENT PHARMA INCOME DATA
Net Sales Rs m41,84746,53566,76458,56960,021 
Other income Rs m3812,8562,2562,2332,988 
Total revenues Rs m42,22949,39069,02060,80263,009 
Gross profit Rs m9,51510,20227,33013,77313,493 
Depreciation Rs m8701,9072,3763,0694,086 
Interest Rs m5861,7521,8402,0563,085 
Profit before tax Rs m8,4409,39825,37110,8819,310 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00-1,93600 
Tax Rs m1,8011,8886,1021,5452,529 
Profit after tax Rs m6,6397,50917,3339,3366,781 
Gross profit margin %22.721.940.923.522.5 
Effective tax rate %21.320.124.114.227.2 
Net profit margin %15.916.126.015.911.3 
TORRENT PHARMA BALANCE SHEET DATA
Current assets Rs m34,04540,98346,88248,79452,623 
Current liabilities Rs m21,74627,04632,85527,38352,022 
Net working cap to sales %29.430.021.036.61.0 
Current ratio x1.61.51.41.81.0 
Inventory Days Days88847497120 
Debtors Days Days96125795976 
Net fixed assets Rs m14,09534,72039,00742,07985,016 
Share capital Rs m846846846846846 
"Free" reserves Rs m17,27225,58334,09542,65545,376 
Net worth Rs m19,02426,43034,94143,50146,222 
Long term debt Rs m7,44521,72918,50122,40841,115 
Total assets Rs m50,69879,64190,57997,021142,432 
Interest coverage x15.46.414.86.34.0 
Debt to equity ratio x0.40.80.50.50.9 
Sales to assets ratio x0.80.60.70.60.4 
Return on assets %14.311.621.211.76.9 
Return on equity %34.928.449.621.514.7 
Return on capital %34.123.247.319.614.2 
Exports to sales %37.430.443.300 
Imports to sales %8.26.06.900 
Exports (fob) Rs m15,66514,13628,93400 
Imports (cif) Rs m3,4162,8014,58400 
Fx inflow Rs m16,86214,26529,18520,06614,580 
Fx outflow Rs m5,1965,1846,0215,3043,600 
Net fx Rs m11,6669,08123,16514,76210,980 
TORRENT PHARMA CASH FLOW
From Operations Rs m 5,994 8,102 27,421 10,088 8,942 
From Investments Rs m -3,558 -21,623 -8,379 -7,869 -47,070 
From Financial Activity Rs m 864 12,123 -14,352 -1,929 34,174 
Net Cashflow Rs m 3,300 -1,399 4,375 177 -3,655 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 71.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 7.0%
FIIs 12.6%
ADR/GDR 0.0%
Free float 8.8%
Shareholders 26,511
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Torrent House, Off Ashram Road, Ahmedabad - 380 009
E-MAIL maheshagrawal@torrentpharma.com WEB www.torrentpharma.com
TELEPHONE (079) 2658 5090 FAX (079) 2658 2100
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Sudhir Mehta COMP SEC: Mahesh Agarwal YEAR OF INC: 1973 BSE CODE: 500420 FV (Rs): 5 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA  ALKEM LABORATORIES  SUVEN LIFESCIENCES  DIVIS LABORATORIES  ALEMBIC PHARMA  

Compare TORRENT PHARMA With:   AUROBINDO PHARMA  ALKEM LABORATORIES  SUVEN LIFESCIENCES  DIVIS LABORATORIES  ALEMBIC PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; FMCG Stocks Advance(12:30 pm)

Share markets in India are presently trading on a positive note. The BSE Sensex is trading up by 76 points while the NSE Nifty is trading up by 12 points.

Views on news

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS